Amber Compounding Pharmacy

Amber Compounding Pharmacy is a specialized pharmaceutical service provider based in Singapore that focuses on personalized medication solutions for human and veterinary patients. Founded in 2008, the company prepares custom-tailored formulations in various dosage forms, including topicals, oral liquids, and bio-identical hormones, specifically addressing clinical needs that commercially available drugs cannot meet. Their expertise spans therapeutic areas such as dermatology, pain management, pediatrics, and nutritional health. In late 2025, the company was acquired by Fagron, a global leader in pharmaceutical compounding, to strengthen its presence in the Southeast Asian market. Amber Compounding Pharmacy operates under ISO 9001 standards and maintains retail and laboratory operations in Singapore and Malaysia.